Breaking the Tuberculosis Cycle: Another Look at the Impact of Chemotherapy
Abstract
Writers in the history of medicine have become increasingly skeptical of the contribution medicine may have made to the improvement of health in industrial countries (Illich, 1975). Chemotherapy of tuberculosis of the lung (TB), however, is tentatively accepted as an exception of the rule by some, e.g. Fuchs (1975). This paper is an attempt at estimating the impact of TB chemotherapy jointly with the influences of other factors, such as living conditions, income, and public outlays on health care. Its novel feature lies in a systems approach: For example, feedbacks from quicker recovery from TB to reduced risk of infection are allowed for. After some historical notes on the social and medical aspects of TB, a model of the full TB cycle is sketched. The subsequent section deals with the data and presents some estimation results. These results are discussed and evaluated in the final section.
Keywords
Labor Income Scarlet Fever Historical Note Real Earning Public Health ExpenditurePreview
Unable to display preview. Download preview PDF.
References
- Fuchs VR (1975) Who Shall Live? Health, Economics, and Social Choice. Basic Books, New YorkGoogle Scholar
- Gsell O (1977) Tuberkulose und Pneumologie im Wandel über 100 Jahre: 1880–1980 (Tuberculosis and Pneumology over 100 years: 1880–1980). In: Praxis der Pneumologie, 31: 330–337Google Scholar
- Haefliger E (1981) Fakten zur Tuberkulose-Endemie (Facts on the Endemics of Tuberkulosis). In: Schweiz. Rundschau Med (Praxis) 70: 60–67Google Scholar
- Illich I (1975) Medical Nemesis. Calder & Boyars, LondonGoogle Scholar
- Junker E, Klima H (1982) Zur tuberkulösen Durchseuchung in Oesterreich (Contamination by tuberculosis in Austria). In: Praxis und Klinik der Pneumologie, 36, 12: 502–507PubMedGoogle Scholar
- Kmenta J (1971) Elements of Econometrics. Macmillan, New YorkGoogle Scholar
- Pedrizet S, Poisson N (1982) Epidémiologie de la tuberculose dans les pays développés. In: Médecine et Hygiene 40: 1485–1492Google Scholar
- Reekie WD (1982) An assessment of the benefits of the diffusion of an innovation. In: Research Policy, 11: 261–266CrossRefGoogle Scholar